- Welcome – John Harris, Chief Executive OBN and Keith Errey, Chief Executive Isansys
- Oxford AHSN update including Annual Review 2015/16 – Prof Gary Ford, Chief Executive
- Oxford AHSN Medicines Optimisation Clinical Network update – Dr Lindsey Roberts
- Discussion on mid-cap companies chaired by Dr Nick Scott-Ram, Oxford AHSN Director of Commercial Development, featuring:
- Closing remarks – Nigel Keen, Chairman, Oxford AHSN
- Networking and light refreshments
Book your place here.